Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.19.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Income Statement [Abstract]    
Product sales $ 437 $ 1,726
Operating cost and expense    
Cost of product sales 4,681 5,436
Research and development cost 620 1,475
General and administrative expense 4,016 1,775
Total operating expense 9,317 8,686
Loss from operations (8,880) (6,960)
Other income and expense    
Interest expense (2,889) (587)
Interest and other income 63 17
Total other expense, net (2,826) (570)
Loss before income tax expense (11,706) (7,530)
Income tax expense (2) (2)
Net loss $ (11,708) $ (7,532)
Weighted average shares outstanding, basic and diluted (in shares) 43,514,225 27,768,008
Basic and diluted net loss per share (in dollars per share) $ (0.27) $ (0.27)